NCT00983528 2020-08-12Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic LeukemiaUniversity of California, San DiegoPhase 1/2 Terminated6 enrolled 6 charts
NCT00617929 2017-12-28Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated12 enrolled 12 charts
NCT00708721 2017-06-01Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaUniversity of UtahPhase 1/2 Terminated11 enrolled 11 charts